Medical Net (TSE:3645) Research & Development: 円0 Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3645 Medical Net Inc TSE:3645
61 GF Score
Price 円246.00
GF Value 円413.66
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medical Net Research & Development?

Medical Net TSE:3645 -3.15% 61 Research & Development is 円0 Mil as of Feb. 2026. GuruFocus rates TSE:3645 with a GF Score™ of 61/100 and a GF Value™ of 円413.66 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Medical Net's Research & Development for the three months ended in Feb. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was 円0 Mil.

Medical Net  (TSE:3645) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medical Net Research & Development Related Terms

Medical Net Research & Development Historical Data

* Premium members only.

The historical data trend for Medical Net's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Net Research & Development Chart

Medical Net Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medical Net Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Nov24 Feb25 May25 Nov25 Feb26 May26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3645
61GF Score
Medical Net Inc TSE:3645
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Net Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Medical Net (TSE:3645) has a Research & Development of 円0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Medical Net and its competitors.
Is Medical Net's Research & Development too high?
Medical Net's current Research & Development is 円0 Mil. Overall, Medical Net has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Net's Research & Development compare to GOOGL and META?
Medical Net's Research & Development of 円0 Mil can be compared against companies in the Interactive Media industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Interactive Media company?
A good Research & Development depends on the Interactive Media industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Medical Net and its competitors. Medical Net's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Net stock overvalued right now?
Based on GuruFocus' analysis, Medical Net (TSE:3645) is currently considered Significantly Undervalued. The stock's GF Value™ is 円413.66, compared to a current price of 円246.00 — trading 40.5% below its estimated fair value. The current Research & Development is 円0 Mil. Medical Net's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Medical Net (TSE:3645), the current Research & Development is 円0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Net (TSE:3645) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Net stock appears to be undervalued. The current stock price of 円246.00 is trading 40.5% below its estimated GF Value™ of 円413.66. GuruFocus considers Medical Net to be Significantly Undervalued.

Key valuation signals for TSE:3645:

  • Research & Development: 円0 Mil
  • GF Value™: 円413.66 vs. price of 円246.00 (40.5% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the TSE:3645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical Net Business Description

Address 1-34-14 Hatagaya, 3rd Floor, Takara Building, Shibuya-ku, Tokyo, JPN, 151-0072
Medical Net Inc operates as a service-based holding company engaged in various healthcare-related businesses. It manages four main reporting segments: Media Platform, Medical Institution Management Support, Medical BtoB, and Cloud Integration. The Media Platform segment runs specialized portal websites focused on dentistry, beauty, and health. The Medical Institution Management Support segment offers SEO and listing advertisement services, website production and maintenance, and sales and operational support to dental clinics. The Medical BtoB segment manages member-based dental industry portals and provides research and marketing services. The Cloud Integration segment develops and maintains POS systems for retailers, manufacturers, and hospitals, primarily in Thailand.
61GF Score

Get the complete analysis for TSE:3645

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円246.00
Price
円413.66
GF Value